Sanofi wins approval for Lumizyme successor, although uptake remains a mystery
It’s not yet clear how many patients will actually take it, but for the first time in 15 years, there is a new treatment available …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
